| 6TWC: reference: De novo development of proteolytically resistant therapeutic peptides for oral administration., Kong XD, Moriya J, Carle V, Pojer F, Abriata LA, Deyle K, Heinis C, Nat Biomed Eng. 2020 May;4(5):560-571. doi: 10.1038/s41551-020-0556-3. Epub 2020 , May 11. PMID: 32393891 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).